| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86671 |
CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) |
108 |
zyl |
2024-11-22 |
| 86672 |
DOTA di(tBu)ester；913542-71-9 |
118 |
wyh |
2024-11-22 |
| 86673 |
10,10'-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸]，三氟乙酸盐；1175002-77-3 |
97 |
wyh |
2024-11-22 |
| 86674 |
(R)-tert-Bu4-DOTAGA；817562-90-6 |
111 |
wyh |
2024-11-22 |
| 86675 |
DOTA-Bevacizumab DOTA-贝伐单抗 |
114 |
zcy |
2024-11-22 |
| 86676 |
10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸，三氟乙酸盐 |
103 |
wyh |
2024-11-22 |
| 86677 |
DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac |
113 |
zcy |
2024-11-22 |
| 86678 |
DOTA-HYNIC-IPSMA |
107 |
wyh |
2024-11-22 |
| 86679 |
PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 |
256 |
zcy |
2024-11-22 |
| 86680 |
CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
93 |
zyl |
2024-11-22 |
| 86681 |
(S)-N-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYL)-6-(METHYL(3-(PIPERAZIN-1-YL)PROPYL)AMINO)QUINOLINE-4-CARBOXAMIDE |
115 |
wyh |
2024-11-22 |
| 86682 |
DOTA(Tris)-EA-TEG-NH2-CBZ DOTA(Tris)-乙胺(EA)偶联四甘醇(TEG) |
200 |
zcy |
2024-11-22 |
| 86683 |
DOTA-octreotide,大环配体奥曲肽 |
133 |
zyl |
2024-11-22 |
| 86684 |
N2-Acetyl-N6-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-L-lysyl-L-prolyl-N2-methyl-L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-3-methyl-L-valyl-L-leucine |
94 |
wyh |
2024-11-22 |
| 86685 |
DOTA-Ts29.2 DOTA偶联单克隆抗体Ts29.2 |
120 |
zcy |
2024-11-22 |
| 86686 |
DOTA-FAMP α螺旋肽偶联DOTA大环配体 |
113 |
zcy |
2024-11-22 |
| 86687 |
DOTA-NT8-13(靶向NTR1) |
117 |
zcy |
2024-11-22 |
| 86688 |
DOTA Conjugated JM#21 derivative 7 ；3033865-40-3 |
130 |
wyh |
2024-11-22 |
| 86689 |
4-Aminobutyl-DOTA-tris(t-butyl ester) Hexafluorophosphate |
91 |
wyh |
2024-11-22 |
| 86690 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide |
90 |
wyh |
2024-11-22 |
| 86691 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1-(2,5-dioxo-1-pyrrolidinyl) ester |
97 |
wyh |
2024-11-22 |
| 86692 |
DOTA-MC1RL 1，4，7，10-四氮杂环十二烷-1，4，7，10-四乙酸缀合MC1R特异性支架 |
127 |
zcy |
2024-11-22 |
| 86693 |
钆布醇杂质20 ；229312-34-9 |
144 |
wyh |
2024-11-22 |
| 86694 |
DOTA-[Nle]-cCCK 科研定制 |
140 |
zcy |
2024-11-22 |
| 86695 |
DOTA-(COOt-Bu)3-CH2-Alkynyl ；1189194-64-6 |
95 |
wyh |
2024-11-22 |
| 86696 |
FITC-PEG2-TATE ；1027160-33-3 |
117 |
wyh |
2024-11-22 |
| 86697 |
DOTA-peg4-LLP2AVLA-4 齐岳定制 |
117 |
zcy |
2024-11-22 |
| 86698 |
蛙皮素肽功能化金纳米颗粒 BBN-AuNPs |
110 |
zcy |
2024-11-22 |
| 86699 |
RGD-DOTA的结构特点 |
119 |
wyh |
2024-11-22 |
| 86700 |
DOTA tris(TBE)-amido-dPEG-bromoacetamide |
101 |
wyh |
2024-11-22 |
| 86701 |
DOTA-PEG-OPSS-AuNP DOTA-PEG-邻吡啶基二硫化物修饰纳米金纳米粒子 |
132 |
zcy |
2024-11-22 |
| 86702 |
DOTA-PEG(23)-MAL*2TFA |
103 |
wyh |
2024-11-22 |
| 86703 |
DOTA偶联PSMA抑制剂 DOTA-PSMA |
113 |
zcy |
2024-11-22 |
| 86704 |
DOTA-PEG(11)-bromoacetamide*2TFA |
117 |
wyh |
2024-11-22 |
| 86705 |
Gn-PAMAM-(TmDOTA(-))(x)(其中n = 1-4，x = 6-39) 齐岳定制 |
127 |
zcy |
2024-11-22 |
| 86706 |
DOTA-(AF)SAv 1，4，7，10-四氮杂环十二烷-N，N′，N″，N″-四乙酸(DOTA)-(AF)SAv |
109 |
zcy |
2024-11-22 |
| 86707 |
PAMAM-DOTA DOTA缀合PAMAM树状大分子 |
151 |
zcy |
2024-11-22 |
| 86708 |
1374865-01-6；10-[2-[[3-(11,12-二脱氢二苯并[B,F]氮杂环辛-5(6H)-基)-3-氧代丙基]氨基]-2-氧代乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸 |
125 |
wyh |
2024-11-22 |
| 86709 |
DOTA-(D-Glu)6-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 齐岳定制 |
128 |
zcy |
2024-11-22 |
| 86710 |
DOTA唑来膦酸盐 ，1908409-18-6 ，DOTA Zoledronate |
121 |
wyh |
2024-11-22 |
| 86711 |
DOTA-C225-AuNPs DOTA修饰西妥昔单抗偶联金纳米颗粒 |
168 |
zcy |
2024-11-22 |
| 86712 |
FAP结合肽大环化合物；2581741-18-4 |
187 |
wyh |
2024-11-22 |
| 86713 |
DOTA-DGlu-Ala-Tyr DOTA偶联受体特异性肽 |
106 |
zcy |
2024-11-22 |
| 86714 |
三（叔丁氧羰基甲基）DOTA氢溴酸盐；137076-54-1 |
114 |
wyh |
2024-11-22 |
| 86715 |
DOTA-h173 双功能螯合剂DOTA偶联h173 |
112 |
zcy |
2024-11-22 |
齐岳微信公众号
官方微信
库存查询